Featured News

Join the Solutions for Celiac Study where you get access to blood testing, symptom tracking tools, and celiac specialists focused on your disease.

Anokion SA announced successful completion of its Phase 1 clinical trial evaluating KAN-101 for the treatment of celiac disease, with promising results.

A study from the University of Chicago has demonstrated that B-cells are required for the development of villous atrophy (intestinal damage) in celiac disease. This finding provides support for the exploration of B-cell–directed therapies for the treatment of celiac disease.

Celiac disease patients are at an increased risk, albeit small, of cancer, and the findings from these studies confirm the importance of a healthy immune system in cancer prevention. For patients with celiac disease, adhering to a strict, gluten-free diet is critical to maintaining a healthy immune system.

Researchers found higher rates of skin disease in patients with celiac disease compared to controls, including increased risks for eczema, psoriasis, urticaria, vitiligo, acne, and alopecia areata.

We understand the holidays can be a challenging time of year for those with celiac disease and other gluten-related disorders. Take the guesswork out of your gluten-free diet with GlutenDetect, the only at-home test to self-monitor accidental gluten exposure.

researchers concluded that patients with celiac disease who are infected with COVID-19 are not at higher risk of hospitalization.

Celiac disease is estimated to affect 1 in 100 people worldwide. Are you the one? Find out if your symptoms could be caused by gluten using our Symptoms Assessment Tool, developed with the support of CDF Proud Sponsor Schär.

For the first time ever, the NIH has released a Notice of Special Interest to provide dedicated research funding for the study of celiac disease.

I am pleased to share a research grant awarded to the Dubcovsky Lab at UC Davis for Development of a Novel Dietary Treatment for Celiac Disease that may significantly reduce the suffering experienced by our patient community.